{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:43:41Z","timestamp":1789386221200,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.contraception.2020.01.009","type":"journal-article","created":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T19:36:49Z","timestamp":1580499409000},"page":"302-308","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["A non-inferiority study of outpatient mifepristone-misoprostol medical abortion at 64\u201370\u00a0days and 71\u201377\u00a0days of gestation"],"prefix":"10.1016","volume":"101","author":[{"given":"Ilana G.","family":"Dzuba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curtiss","family":"Hannum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Steve","family":"Lichtenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elba Margarita","family":"Lugo Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen thi Nhu","family":"Ngoc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashlesha","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulnara","family":"Rzayeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricio","family":"Sanhueza Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Tsertsvadze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverly","family":"Winikoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2020.01.009_b0005","series-title":"Abortion incidence and service availability in the United States, 2017","author":"Jones","year":"2019"},{"key":"10.1016\/j.contraception.2020.01.009_b0010","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.contraception.2015.06.018","article-title":"Outpatient medical abortion is safe and effective through 70 days gestation","volume":"92","author":"Abbas","year":"2015","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2020.01.009_b0015","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/AOG.0000000000000897","article-title":"Mifepristone with buccal misoprostol for medical abortion: a systematic review","volume":"126","author":"Chen","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2020.01.009_b0020","unstructured":"Jones RK, Boonstra HD. The public health implications of the FDA update to the medication abortion label. https:\/\/www.guttmacher.org\/article\/2016\/06\/public-health-implications-fda-update-medication-abortion-label June 30, 2016. Accessed June 6, 2019."},{"key":"10.1016\/j.contraception.2020.01.009_b0025","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.contraception.2019.05.006","article-title":"Medical abortion with mifepristone and vaginal misoprostol between 64 and 70 days' gestation","volume":"100","author":"Hsia","year":"2019","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2020.01.009_b0030","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0010-7824(02)00366-9","article-title":"Randomized trial of oral versus vaginal misoprostol 2 days after mifepristone 200 mg for abortion up to 63 days of pregnancy","volume":"66","author":"Schaff","year":"2002","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2020.01.009_b0035","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0968-8080(15)43825-X","article-title":"Safety, efficacy and acceptability of outpatient mifepristone-misoprostol medical abortion through 70 days since last menstrual period in public sector facilities in Mexico City","volume":"22","author":"Sanhueza Smith","year":"2015","journal-title":"Reprod Health Matters"},{"key":"10.1016\/j.contraception.2020.01.009_b0040","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3109\/13625187.2011.555568","article-title":"Mifepristone followed by home administration of buccal misoprostol for medical abortion up to 70 days of amenorrhoea in a general practice in Cura\u00e7ao","volume":"16","author":"Boersma","year":"2011","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2020.01.009_b0045","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.contraception.2015.01.005","article-title":"Efficacy and safety of medical abortion using mifepristone and buccal misoprostol through 63 days","volume":"91","author":"Gatter","year":"2015","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2020.01.009_b0050","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/AOG.0b013e3182755763","article-title":"Significant adverse events and outcomes after medical abortion","volume":"121","author":"Cleland","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2020.01.009_b0055","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/AOG.0b013e31818d8eb4","article-title":"Two distinct oral routes of misoprostol in mifepristone medical abortion","volume":"112","author":"Winikoff","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2020.01.009_b0060","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/humrep\/17.1.92","article-title":"A randomized comparison of medical abortion and surgical vacuum aspiration at 10\u201313 weeks gestation","volume":"17","author":"Ashok","year":"2002","journal-title":"Human Reprod"},{"key":"10.1016\/j.contraception.2020.01.009_b0065","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1471-0528.1999.tb08320.x","article-title":"Medical termination of pregnancy at 63 to 83 days gestation","volume":"106","author":"Gouk","year":"1999","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2020.01.009_b0070","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1067\/mob.2003.267","article-title":"Medical abortion at 64 to 91 days of gestation: a review of 483 consecutive cases","volume":"188","author":"Hamoda","year":"2003","journal-title":"Am J Obstetrics Gynecol"},{"key":"10.1016\/j.contraception.2020.01.009_b0075","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.contraception.2004.10.015","article-title":"Medical abortion at 9\u201313 weeks' gestation: a review of 1076 consecutive cases","volume":"71","author":"Hamoda","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2020.01.009_b0080","unstructured":"Medical management of abortion. Geneva: World Health Organization; 2018."},{"key":"10.1016\/j.contraception.2020.01.009_b0085","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.contraception.2018.11.002","article-title":"Medical abortion in the late first trimester: a systematic review","volume":"99","author":"Kapp","year":"2019","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2020.01.009_b0090","unstructured":"An overview of abortion laws. www.guttmacher.org\/state-policy\/explore\/overview-abortion-laws. Guttmacher Institute; Accessed September 20, 2017."},{"key":"10.1016\/j.contraception.2020.01.009_b0095","doi-asserted-by":"crossref","first-page":"e211","DOI":"10.1016\/j.whi.2014.01.003","article-title":"Out-of-pocket costs and insurance coverage for abortion in the United States","volume":"24","author":"Roberts","year":"2014","journal-title":"Women's Health Issues"},{"key":"10.1016\/j.contraception.2020.01.009_b0100","doi-asserted-by":"crossref","unstructured":"Medical management of first-trimester abortion: Society of Family Planning clinical guideline. Contraception. 2014;89:148-61.","DOI":"10.1016\/j.contraception.2014.01.016"},{"key":"10.1016\/j.contraception.2020.01.009_b0105","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1097\/AOG.0b013e31826c315f","article-title":"Extending outpatient medical abortion services through 70 days of gestational age","volume":"120","author":"Winikoff","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2020.01.009_b0110","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0197-2456(82)90024-1","article-title":"Proving the null hypothesis in clinical trials","volume":"3","author":"Blackwelder","year":"1982","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.contraception.2020.01.009_b0115","unstructured":"http:\/\/www.sealedenvelope.com\/power\/binary-noninferior\/. Accessed August 12, 2013."},{"key":"10.1016\/j.contraception.2020.01.009_b0120","series-title":"Statistical power analysis for the behavioral sciences","author":"Cohen","year":"1977"},{"key":"10.1016\/j.contraception.2020.01.009_b0125","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/aogs.13537","article-title":"Expanding a woman's options to include home use of misoprostol for medical abortion up until 76 days: an observational study of efficacy and safety","volume":"98","author":"Larsson","year":"2019","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.contraception.2020.01.009_b0130","unstructured":"Castillo PW, Sanhueza Smith P, Lugo Hern\u00e1ndez EM, Casta\u00f1eda Vivar JJ, Bousi\u00e9guez M, Dzuba IG. Does a repeat dose of 800 mcg misoprostol following mifepristone improve outcomes in the later first trimester? A retrospective chart review in Mexico City. Poster. National Abortion Federation's annual meeting; 2017."},{"key":"10.1016\/j.contraception.2020.01.009_b0135","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00006254-197802000-00001","article-title":"Indispensability of the human corpus luteum in the maintenance of early pregnancy: luteectomy evidence","volume":"33","author":"Csapo","year":"1978","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.contraception.2020.01.009_b0140","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S0015-0282(16)54178-8","article-title":"Progesterone production in early pregnancy","volume":"55","author":"Nakajima","year":"1991","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2020.01.009_b0145","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.contraception.2019.05.013","article-title":"TelAbortion: evaluation of a direct to patient telemedicine abortion Service in the United States","volume":"100","author":"Raymond","year":"2019","journal-title":"Contraception"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782420300287?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782420300287?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T21:10:59Z","timestamp":1762117859000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782420300287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0010782420300287"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2020.01.009","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A non-inferiority study of outpatient mifepristone-misoprostol medical abortion at 64\u201370\u00a0days and 71\u201377\u00a0days of gestation","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2020.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}